Cholangiocarcinoma Clinical Trials in Göttingen
2 recruitingGöttingen, Germany
Showing 1–2 of 2 trials
Recruiting
Phase 2
Phase II Study Evaluating Ivosidenib Maintenance After SOC Adjuvant Chemotherapy in Curative mIDH1 Cholangiocarcinoma
CholangiocarcinomaIDH Mutation
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest40 enrolled7 locationsNCT07260175
Recruiting
Phase 2
Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma
Extrahepatic CholangiocarcinomaUnresectable Perihilar or Ductal CCA
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest42 enrolled10 locationsNCT06440993